Table 2. The effects of Cuc IIa on mouse H22 liver cancer through pouring into stomacha.
| Dosage | Administration method | Animal number | Animal body weight (g) | Cancer weight (g) | Inhibition | |
|---|---|---|---|---|---|---|
| Sample | (mg kg−1 per day) | Ig × 10qd | Start/end | Start/end | X±s.d. | efficiency |
| Cuc IIa | 90 | Ig × 10qd | 10/10 | 19.1/25.7 | 1.96±0.16 | 38.17 |
| Cuc IIa | 60 | Ig × 10qd | 10/10 | 19.3/26.3 | 2.14±0.20 | 32.09 |
| Cuc IIa | 30 | Ig × 10qd | 10/10 | 19.0/26.0 | 2.31±0.21 | 27.13 |
| Control | Solvent | Ig × 10qd | 10/10 | 19.3/26.5 | 3.17±0.32 |
a
Compared with negative control, P<0.01. The difference is significant.